Furthermore, during the pathological progression of T2DM, PPs can downregulate the levels of abnormally elevated indicators such as blood glucose, insulin, total blood lipids, and MDA, upregulate the level of HDL-C—a protective lipid indicator—and enhance the antioxidant activities of SOD and CAT [242]. This evidence concerns the gene SOD1 and type 2 diabetes mellitus.